- Molecular NameNADH
- Synonymbeta-DPNH; beta-NADH; Coenzyme I, reduced; Cozymase I, reduced; dihydrodiphosphopyridine nucleotide; dihydronicotinamide adenine dinucleotide; Diphosphopyridine nucleotide; diphosphopyridine nucleotide reduced; DPN; DPN+; DPNH; NAD-reduced; NAD+; NADH+H+; NADH2; Nicotinamide adenine dinucleotide; nicotinamide adenine dinucleotide reduced; Nicotinaminde-Adenine-Dinucleotide
- Weight665.446
- Drugbank_IDDB00157
- ACS_NO58-68-4
- Show 3D model
- LogP (experiment)N/A
- LogP (predicted, AB/LogP v2.0)-4.82
- pkaN/A
- LogD (pH=7, predicted)-9.66
- Solubility (experiment)N/A
- LogS (predicted, ACD/Labs)(ph=7)0.18
- LogSw (predicted, AB/LogsW2.0)2.31
- Sw (mg/ml) (predicted, ACD/Labs)449.44
- No.of HBond Donors10
- No.of HBond Acceptors21
- No.of Rotatable Bonds11
- TPSA337.24
- StatusFDA approved
- AdministrationN/A
- PharmacologyA coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH).
- Absorption_valueN/A
- Absorption (description)N/A
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmN/A
- Half lifeN/A
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)N/A
- LD50 (mouse)N/A